The renin angiotensin system and the metabolic syndrome.
The renin angiotensin system (RAS; most well-known for its critical roles in the regulation of cardiovascular function and hydromineral balance) has regained the spotlight for its potential roles in various aspects of the metabolic syndrome. It may serve as a causal link among obesity and several co-morbidities. Drugs that reduce the synthesis or action of angiotensin-II (A-II; the primary effector peptide of the RAS) have been used to treat hypertension for decades and, more recently, clinical trials have determined the utility of these pharmacological agents to prevent insulin resistance. Moreover, there is evidence that the RAS contributes to body weight regulation by acting in various tissues. This review summarizes what is known of the actions of the RAS in the brain and throughout the body to influence various metabolic disorders. Special emphasis is given to the role of the RAS in body weight regulation. The paper represents an invited review by a symposium, award winner or keynote speaker at the Society for the Study of Ingestive Behavior [SSIB] Annual Meeting in Portland, July 2009.
de Kloet
Annette D
AD
Program in Neuroscience University of Cincinnati, Cincinnati, OH 45237, United States. dekloead@mail.uc.edu
Krause
Eric G
EG
Woods
Stephen C
SC
D000818:Animals; D001835:Body Weight / Q000502:physiology; D006801:Humans; D007328:Insulin / Q000378:metabolism; D024821:Metabolic Syndrome / Q000378:metabolism* / Q000503:physiopathology*; D012084:Renin-Angiotensin System / Q000502:physiology*
D007328:Insulin
Behav Neurosci. 1988 Dec;102(6):953-60
2850816
Neurosci Lett. 1982 Apr 16;29(2):123-7
6283434
J Intern Med. 2008 Apr;263(4):336-52
18312311
Biochem Biophys Res Commun. 2002 Jun 7;294(2):441-7
12051731
J Physiol. 2007 Oct 15;584(Pt 2):613-23
17702818
FEBS Lett. 2001 Apr 27;495(3):197-200
11334891
Physiol Behav. 2009 Aug 4;98(1-2):192-7
19465040
Antioxid Redox Signal. 2007 Jul;9(7):869-78
17508912
J Clin Invest. 2002 Jun;109(11):1417-27
12045255
Am J Physiol. 1982 Jan;242(1):R136-40
7036759
J Pharmacol Exp Ther. 1998 Aug;286(2):718-26
9694926
J Hypertens. 1998 May;16(5):571-5
9797167
Exp Physiol. 2008 May;93(5):665-75
18263657
J Endocrinol. 1999 May;161(2):317-22
10320830
J Pharmacol Exp Ther. 2005 Jun;313(3):1035-45
15681656
Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1074-81
15657091
Diabetes. 2004 Apr;53(4):989-97
15047614
J Hepatol. 2009 Jun;50(6):1226-35
19395110
Am J Hypertens. 2007 May;20(5):579-86
17485025
Brain Res. 1982 Aug 12;245(2):317-25
6289966
J Biol Chem. 2005 Aug 26;280(34):30113-9
15983030
Am J Physiol. 1993 Dec;265(6 Pt 1):E860-5
8279541
J Mol Med (Berl). 2001 Apr;79(2-3):71-3
11357940
Pharmacol Ther. 2010 Jan;125(1):27-38
19723538
FASEB J. 2001 Dec;15(14):2727-9
11606482
Diabetologia. 1998 Feb;41(2):127-33
9498644
Science. 2001 Dec 7;294(5549):2166-70
11739957
Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R781-8
18650320
Am J Physiol. 1994 Mar;266(3 Pt 1):E453-8
8166267
Curr Opin Nephrol Hypertens. 2004 May;13(3):325-32
15073492
Metabolism. 2006 Apr;55(4):478-88
16546478
Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E227-32
15082419
Science. 1971 Jul 2;173(3991):64-5
4325865
Brain Res. 1997 May 23;757(2):218-27
9200750
J Clin Invest. 1996 Aug 1;98(3):671-9
8698858
Eur J Pharmacol. 2006 Dec 15;552(1-3):112-22
17064684
Diabetes Care. 2005 Sep;28(9):2261-6
16123505
Endocrinology. 2007 Nov;148(11):5442-50
17690163
J Neural Transm Gen Sect. 1994;98(2):159-64
7734113
Cell Metab. 2007 Dec;6(6):506-12
18054319
N Engl J Med. 1991 Apr 18;324(16):1098-104
1759997
Hypertension. 1990 Jun;15(6 Pt 2):867-71
2351437
Histochemistry. 1988;89(4):323-31
3410745
Front Neuroendocrinol. 1997 Oct;18(4):383-439
9344632
Biochem Biophys Res Commun. 2002 Jan 25;290(3):1084-9
11798186
Am J Physiol. 1993 Jun;264(6 Pt 1):C1570-6
8333506
Lancet. 2007 Apr 7;369(9568):1208-19
17416265
Gastroenterology. 2002 Nov;123(5):1667-76
12404241
Clin Exp Pharmacol Physiol. 2005 Apr;32(4):302-7
15810996
Am J Physiol. 1998 May;274(5):E867-76
9612245
J Neural Transm Suppl. 1991;34:129-37
1667868
Physiol Behav. 2008 Mar 18;93(4-5):820-5
18191966
Diabetologia. 2009 May;52(5):752-64
19283361
Diabetes Metab. 2004 Dec;30(6):487-96
15671918
Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E891-5
14749209
Science. 1998 May 29;280(5368):1378-83
9603721
Diabetes Obes Metab. 2003 Nov;5(6):462-7
14617233
Endocrinology. 1997 Apr;138(4):1512-9
9075710
J Hypertens. 2005 Oct;23(10):1777-81
16148594
Circ Res. 1995 Jan;76(1):1-15
8001266
J Hypertens. 2004 Mar;22(3):645-52
15076172
Exp Physiol. 2009 Jan;94(1):130-7
18723579
Endocrinology. 1994 Nov;135(5):2030-6
7956925
Curr Opin Pharmacol. 2008 Apr;8(2):127-32
18243793
Nat Rev Neurosci. 2003 Nov;4(11):901-9
14595401
J Clin Invest. 1997 Nov 1;100(9):2158-69
9410892
Biochem Biophys Res Commun. 1998 Sep 8;250(1):77-82
9735335
JAMA. 2006 Apr 5;295(13):1549-55
16595758
Trends Pharmacol Sci. 2009 May;30(5):234-9
19359049
J Am Coll Cardiol. 2005 Sep 6;46(5):821-6
16139131
Adv Exp Med Biol. 1996;396:39-47
8726684
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8258-63
12829792
Biochem Biophys Res Commun. 2006 Jun 16;344(4):1224-33
16650382
Endocrinology. 1987 Nov;121(5):1616-26
3665835
Proc Natl Acad Sci U S A. 2008 May 6;105(18):6531-6
18443281
Biochem J. 1997 Feb 15;322 ( Pt 1):235-9
9078267
Am J Physiol. 1993 Aug;265(2 Pt 2):R302-9
8103642
Diabetes. 2008 Feb;57(2):340-7
18025412
Nature. 2000 Apr 6;404(6778):661-71
10766253
Diabetes. 2005 Apr;54(4):991-9
15793237
J Hypertens. 2004 Oct;22(10):1977-82
15361770
Biochem Biophys Res Commun. 2005 Jul 15;332(4):927-33
15922295
Circ Res. 2000 Sep 1;87(5):E1-9
10969042
J Neural Transm (Vienna). 1999;106(7-8):631-44
10907723
Diabetes. 2006 Feb;55(2):367-74
16443769
Am J Physiol. 1997 Mar;272(3 Pt 1):C989-99
9124535
Regul Pept. 1995 May 4;57(1):1-18
7644700
J Clin Invest. 2003 Jul;112(1):83-90
12840062
J Neurosci. 1999 May 15;19(10):3952-61
10234025
Regul Pept. 2004 Jul 15;119(3):213-9
15120483
Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E345-51
18073321
Endocrinology. 1999 Jan;140(1):154-8
9886820
N Engl J Med. 2000 Mar 30;342(13):905-12
10738048
Peptides. 2005 Jul;26(7):1270-7
15949646
Neuroendocrinology. 1995 Apr;61(4):437-44
7783857
Endocrinology. 2001 Jan;142(1):487-92
11145613
Int Immunopharmacol. 2008 Feb;8(2):312-8
18182246
Hypertension. 2005 Mar;45(3):356-62
15630041
Am J Physiol Regul Integr Comp Physiol. 2001 Sep;281(3):R795-802
11506994
Hypertension. 2002 Nov;40(5):609-11
12411451
Lancet. 2003 Mar 29;361(9363):1077-83
12672310
Appetite. 2007 Sep;49(2):353-67
17561308
Endocrinology. 2004 Jan;145(1):169-74
14512436
Am J Physiol Regul Integr Comp Physiol. 2001 Apr;280(4):R1095-104
11247832
Hypertension. 2004 May;43(5):1003-10
15037562
Mol Cancer Ther. 2003 Nov;2(11):1139-47
14617787
Obes Res. 2005 Nov;13(11):1909-14
16339122
JOP. 2001 Jan;2(1):26-32
11862019
J Neurosci. 2003 Jun 15;23(12):5041-9
12832527
Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R422-8
15117728
J Endocrinol. 1999 Jan;160(1):13-9
9854172
Am J Physiol. 1997 Jul;273(1 Pt 2):R236-42
9249555
Hypertension. 1988 Jun;11(6 Pt 2):591-6
2839415
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12490-5
8901609
Biochem J. 2001 Aug 1;357(Pt 3):899-904
11463364
Diabetes Metab. 2004 Dec;30(6):498-505
15671919
Endocrinology. 2009 Sep;150(9):4114-23
19497971
Cancer Lett. 2006 Jan 18;231(2):290-4
16399230
Trends Endocrinol Metab. 2005 Sep;16(7):293-9
16061390
J Biol Chem. 2000 Oct 27;275(43):33238-43
10924499
Horm Metab Res. 2000 Nov-Dec;32(11-12):500-3
11246815
Hypertension. 1992 Apr;19(4):339-44
1555865
Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E955-61
15213064
Br J Cancer. 2005 Aug 22;93(4):425-34
16052213
Diabetologia. 2004 Feb;47(2):240-8
14722647
Am J Physiol Cell Physiol. 2009 Sep;297(3):C601-10
19535516
Cardiovasc Diabetol. 2007 Nov 27;6:36
18042288
Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R943-9
15191907
Compr Ther. 1989 Nov;15(11):51-8
2684484
Int Immunopharmacol. 2008 Feb;8(2):247-53
18182235
J Hypertens. 2006 Aug;24(8):1607-17
16877964
N Engl J Med. 1981 Apr 16;304(16):930-3
7010165
Endocrinology. 1993 Aug;133(2):939-41
8344227
J Hypertens. 2006 Sep;24(9):1809-16
16915030
Circulation. 2005 Apr 12;111(14):1806-13
15809376
Exp Physiol. 2008 May;93(5):519-27
18310257
Am J Hypertens. 2007 Apr;20(4):431-6
17386352
Diabetes. 2002 Jun;51(6):1699-707
12031955
Eur J Pharmacol. 2008 Jan 28;579(1-3):426-32
18078928
Physiol Genomics. 2005 Nov 17;23(3):311-7
16131528
Endocrinology. 2001 Dec;142(12):5220-5
11713218
Physiol Rev. 2006 Jul;86(3):747-803
16816138
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10730-5
12149466
J Clin Invest. 2002 Mar;109(5):603-11
11877468
Endocrinology. 2009 Mar;150(3):1421-8
18948399
Neuroendocrinology. 2000 Nov;72(5):306-17
11124587
Circulation. 2004 May 4;109(17):2054-7
15117841
J Hypertens. 2005 Aug;23(8):1525-30
16003179
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
15181022
Endocrinology. 1991 May;128(5):2248-52
1850346
Diabetologia. 1991 Feb;34(2):119-25
2065846
Nat Med. 2004 Jun;10(6):625-32
15133506
J Mol Endocrinol. 2001 Jun;26(3):155-64
11432370
Endocrinology. 2005 Aug;146(8):3481-9
15878965
Endocrinology. 2008 Dec;149(12):6416-24
18687780